ThomasJ.SchnitzerMDPhD

Rheumatology • Chicago, IL

Osteoarthritis, Osteoporosis & Bone Metabolism

Prof in Physical Medicine & Rehabilitation and Medicine-Rheumatology, Northwestern University Medical School

Join to view full profile

Dr. Schnitzer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Schnitzer's full profile

Already have an account?

Office
345 E Superior St
Chicago, IL 60611
Phone+1 312-238-2784

Fax+1 312-503-1505

Education & Training

UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Rheumatology, 1977 - 1978
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1975 - 1977
Johns Hopkins UniversityResidency, Internal Medicine, 1971 - 1973
Harvard Medical SchoolClass of 1971

Certifications & Licensure

IL State Medical License 1985 - 2026
MI State Medical License 1980 - 1987
MD State Medical License 1973 - 1975
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Rheumatology
American Board of Intenal MedicineRheumatology
American Board of Internal MedicineInternal Medicine

Awards, Honors, & Recognition

Elected Member The American Society for Clinical Investigation, 1984

Clinical Trials

D-cycloserine in the Management of Chronic Low Back Pain Start of enrollment: 2012 Jul 01
Completed
Phase 2
Bone Loss, Fractures, and Management of Bone Health in People With Stroke in Managed Rehabilitation Settings Start of enrollment: 2007 Jul 01
Completed
Effect of Parathyroid Hormone (PTH) and Weight-Bearing on Bone in Spinal Cord Injury (SCI) Start of enrollment: 2009 Jun 01
Completed
Phase 4
Efficacy and Safety of Zoledronic Acid in Acute Spinal Cord Injury: Prevention of Bone Loss Start of enrollment: 2010 Mar 01
Terminated
Phase 2
Effect of Teriparatide, Vibration and the Combination on Bone Mass and Bone Architecture in Chronic Spinal Cord Injury Start of enrollment: 2010 Oct 01
Completed
Phase 2
Effect of Milnacipran in Chronic Neuropathic Low Back Pain Start of enrollment: 2010 Oct 01
Completed
Phase 2
Epidemiology of Osteoarthritis (OA) Pain Start of enrollment: 2012 Mar 01
Completed
Duloxetine in Osteoarthritis (OA) Pain Start of enrollment: 2012 Mar 01
Completed
Phase 4
Efficacy and Safety of Synera in Osteoarthritis Pain Start of enrollment: 2013 Sep 01
Completed
Phase 1, Phase 2
Placebo In Chronic Back Pain - Double-Blind Randomized Control Trial Start of enrollment: 2014 Oct 01
Completed
Phase 4
12 Month Extension Study of the Effect of Teriparatide on Bone in People With Chronic Spinal Cord Injury (SCI) Start of enrollment: 2013 Jan 01
Completed
Phase 2
Effect of Alendronate on Bone in People With Chronic Spinal Cord Injury (SCI) Previously Treated With Teriparatide Start of enrollment: 2014 Apr 01
Completed
Phase 2
Prevention of Bone Loss After Acute SCI by Zoledronic Acid Start of enrollment: 2015 Feb 01
Completed
Phase 2
D-cycloserine for the Treatment of Chronic, Refractory Low Back Pain Start of enrollment: 2018 Mar 30
Terminated
Phase 2
Join now to see all

Publications & Presentations

PubMed

A phase III study to evaluate the long-term safety and efficacy of fasinumab in patients with pain due to osteoarthritis of the knee or hip.
Stephen J DiMartino, Jingning Mei, Thomas J Schnitzer, Haitao Gao, Simon Eng
Osteoarthritis and Cartilage Open. 2024-12-01
1 citations
Use of patient-reported global assessment measures in clinical trials of chronic pain treatments: ACTTION systematic review and considerations.
Dale J Langford, Remington P Mark, Fallon O France, Mahd Nishtar, Meghan Park
Pain. 2024-11-01
Monthly treatment with romosozumab for 1 year increases bone mineral at the hip, but not the knee, in women with chronic spinal cord injury.
Laura E Crack, Narina Simonian, Thomas J Schnitzer, W Brent Edwards
JBMR Plus. 2024-07-01

Journal Articles

Effects of Teriparatide and Vibration on Bone Mass and Bone Strength in People with Bone Loss and Spinal Cord Injury: A Randomized, Controlled Trial*
David Chen, Ki H Kim, Alan S Anschel, Thomas J Schnitzer, Journal of Bone and Mineral Research

Authored Content

Bone Fragility After Spinal Cord Injury: Reductions in Stiffness and Bone Mineral at the Distal Femur and Proximal Tibia as a Function of TimeOctober 2018
Efficacy and Safety of Subcutaneous Tanezumab for the Treatment of Osteoarthritis of the Hip or KneeOctober 2018

Press Mentions

Osteoarthritis Candidate MM-II Shows Durable Pain Relief in Global Phase 2b Study: Sun PharmaMarch 22nd, 2023
First Subjects Randomized and Dosed in the U.S. Under Phase III Pivotal Trial for the Treatment of Pain Associated with Knee OAMay 4th, 2022
Zoledronic Acid Provides Protection Against Bone Loss After Acute Spinal Cord InjuryAugust 9th, 2021
Join now to see all